Impact of Including Drug Spending in Oncology Alternative Payment Models
This study demonstrates a method for understanding the effects of drug spending in the design of alternative payment models.
How Pharmacy Deserts, Biosimilars, and Market Trends Are Shaping Managed Care
Robert F. Kennedy Jr Faces Senate Inquiry Over Deep Cuts to HHS Impacting FDA, CDC, NIH, CMS
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
Areas of Unmet Need Continue to Burden Patients With gMG